Insider Selling: Astera Labs (NASDAQ:ALAB) Director Sells $898,500.00 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Jack Lazar sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the completion of the sale, the director directly owned 87,351 shares of the company’s stock, valued at $10,464,649.80. The trade was a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Astera Labs Stock Performance

NASDAQ ALAB opened at $124.71 on Thursday. The business’s 50 day moving average price is $150.00 and its 200-day moving average price is $168.89. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The company has a market cap of $21.23 billion, a P/E ratio of 102.22, a P/E/G ratio of 2.29 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue was up 91.8% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ALAB. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. BNP Paribas Exane began coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Raymond James Financial initiated coverage on Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $195.89.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ALAB. Lido Advisors LLC boosted its position in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the period. Perigon Wealth Management LLC increased its position in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC increased its position in shares of Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC raised its stake in shares of Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after acquiring an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its stake in shares of Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after acquiring an additional 84 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.